Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

2010673 citationsJournal Articlebronze Open Access

Authors

Salim S. Abdool Karim · Centre for the AIDS Programme of Research in South Africa

Kogieleum Naidoo · University of KwaZulu-Natal

Anneke Grobler · University of KwaZulu-Natal

Nesri Padayatchi · Columbia University

Cheryl Baxter · University of KwaZulu-Natal

Andy Gray · Columbia University

Tanuja N. Gengiah

Abstract

The initiation of antiretroviral therapy during tuberculosis therapy significantly improved survival and provides further impetus for the integration of tuberculosis and HIV services. (ClinicalTrials.gov number, NCT00398996.)

Topics & Keywords

HIV/AIDS drug development and treatment Pneumocystis jirovecii pneumonia detection and treatment Tuberculosis Research and Epidemiology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 362, Issue 8, pp. 697-706

DOI: 10.1056/nejmoa0905848

Field-Weighted Citation Impact: 49.97